The U.K.’s Independent asks whether the $11 Billion in fines that the drug industry has racked up, and related “corporate integrity agreements,” are enough to change the industry’s ways.
The U.K.’s Independent asks whether the $11 Billion in fines that the drug industry has racked up, and related “corporate integrity agreements,” are enough to change the industry’s ways.